![Logo](/assets/logo-d3f1fdf60522f0983e71f9fcc720cb7da5b55c0b748ed5bded3d2fbf81387bf0.png)
PMC:7736111 / 55-779
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3 | 16-21 | Disease | denotes | Death | MESH:D003643 |
19 | 94-104 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
20 | 147-155 | Species | denotes | patients | Tax:9606 |
21 | 181-189 | Species | denotes | patients | Tax:9606 |
22 | 498-506 | Species | denotes | patients | Tax:9606 |
23 | 698-706 | Species | denotes | patients | Tax:9606 |
27 | 81-90 | Disease | denotes | infection | MESH:D007239 |
28 | 138-146 | Disease | denotes | COVID-19 | MESH:C000657245 |
29 | 489-497 | Disease | denotes | COVID-19 | MESH:C000657245 |
30 | 549-557 | Disease | denotes | COVID-19 | MESH:C000657245 |
31 | 683-697 | Disease | denotes | critically ill | MESH:D016638 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 23-31 | Sentence | denotes | Abstract |
T4 | 32-156 | Sentence | denotes | Hyperactivation of the host immune system during infection by SARS-CoV-2 is the leading cause of death in COVID-19 patients. |
T5 | 157-304 | Sentence | denotes | It is also evident that patients who develop mild/moderate symptoms and successfully recover display functional and well-regulated immune response. |
T6 | 305-507 | Sentence | denotes | Whereas a delayed initial interferon response is associated with severe disease outcome and can be the tipping point towards immunopathological deterioration, often preceding death in COVID-19 patients. |
T7 | 508-597 | Sentence | denotes | Further, adaptive immune response during COVID-19 is heterogeneous and poorly understood. |